Cargando…
MicroRNA-122 regulates docetaxel resistance of prostate cancer cells by regulating PKM2
Prostate cancer (PCa), an epithelial malignancy that occurs in the prostate, is the second leading cause of cancer death worldwide. MicroRNAs (miRs/miRNAs) are reported to have important applications in the field of cancer diagnosis and treatment. The present study aimed to investigate the function...
Autores principales: | Zhu, Zhirong, Tang, Guiliang, Yan, Jiajun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7651870/ https://www.ncbi.nlm.nih.gov/pubmed/33178345 http://dx.doi.org/10.3892/etm.2020.9377 |
Ejemplares similares
-
MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma
por: Xu, Qiuran, et al.
Publicado: (2021) -
[Retracted] MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma
por: Xu, Qiuran, et al.
Publicado: (2023) -
Aggressive angiomyxoma of the prostate: A case report
por: Zhu, Zhirong, et al.
Publicado: (2018) -
Identification of biomarker microRNA-mRNA regulatory pairs for predicting the docetaxel resistance in prostate cancer
por: Tu, Jian, et al.
Publicado: (2019) -
Role of microRNAs in the resistance of prostate cancer to docetaxel and paclitaxel
por: Kopczyńska, Ewa
Publicado: (2016)